Key Highlights

  • Agronomics Limited (LSE:ANIC) rose 1.65% on the AIM market of the London Stock Exchange on 20 October 2026.
  • Net asset value per share was 12.93p at 30 June 2026, while the share price of 5.64p represented a 56% discount.
  • Net assets stood at around £140 million, including investments of £138 million.
  • Portfolio companies including Meatly, Clean Food Group, SuperMeat and Tropic Biosciences secured new funding or completed deals.
  • The next quarterly NAV, as at 30 September 2026, is the key upcoming catalyst.

Why Agronomics (LSE:ANIC) Is in Focus Today

Agronomics Limited, the London-listed investment company focused on clean food and cellular agriculture, gained 1.65% on the AIM market on 20 October 2026. LSE:ANIC has long attracted investors who see value in its portfolio of alternative protein and sustainable food businesses, and its steep discount to net asset value continues to draw bargain hunters.

With the third-quarter NAV due in the coming weeks, investors are positioning ahead of the next update on portfolio valuations.

A Wide Discount to Net Asset Value

At 30 June 2026, Agronomics reported unaudited NAV of 12.93p per share, a 1.5% decrease from 13.12p at 31 March 2026. Its share price of 5.64p on the same date represented a 56% discount to NAV, wider than the 49% average over the previous twelve months. Net assets stood at £140 million, including investments of £138 million and cash of £1.6 million.

Under IFRS, unquoted investments are generally carried at cost or the value of the latest priced funding round, which provides a degree of conservatism. For value-focused investors, buying a diversified portfolio at less than half its stated value can be attractive, though the discount reflects market scepticism about the sector.

Portfolio Progress in 2026

Several portfolio companies made progress during the second quarter. Clean Food Group secured a new £4.5 million investment led by Clean Growth Fund in April. Meatly, the cultivated pet food company, completed a £10.4 million Series A round in May. Agronomics led a US$5 million investment in SuperMeat, settled partly in its own shares. HydGene Renewables was selected for an innovation programme run by Greentown Labs with Shell and Technip Energies. Bond Pet Foods received a regulatory milestone in the form of an FDA no-objection letter, and Tropic Biosciences acquired banana propagation business Rahan Meristem for US$20 million.

In January 2026, Agronomics also invested a further AU$3 million in All G, the precision fermentation dairy protein company.

Leadership and Strategy

Agronomics was co-founded by investor Jim Mellon, who serves as executive chair, and Anthony Chow. It invests in companies developing alternatives to traditional meat, dairy, seafood, materials and other agricultural products. Director share purchases, including by Jim Mellon in July 2026, have been seen as a vote of confidence.

Sector Backdrop

Cellular agriculture and precision fermentation have faced a tougher funding environment, with some businesses failing; Agronomics wrote off its investment in Meatable when it was dissolved in December 2025. However, regulatory approvals for cultivated products in several markets and growing commercial partnerships offer reasons for long-term optimism.

Risks Investors Are Weighing

Early-stage food technology companies carry high failure rates, and valuations can fall sharply at down rounds. Agronomics holds limited cash, which constrains its ability to support portfolio companies without raising capital. Currency movements affect valuations of overseas holdings, and the share price discount may persist.

How Agronomics Creates Value

Agronomics does not operate businesses itself. Instead, it takes minority stakes in early and growth-stage companies, often participating in multiple funding rounds. Value is created when portfolio companies raise money at higher valuations, sign commercial partnerships, achieve regulatory approvals or are acquired. Because unquoted holdings are generally valued at cost or the latest funding round, positive events can lift NAV, while down rounds or failures reduce it.

The portfolio covers several technologies. Cultivated meat and pet food companies grow animal cells directly, while precision fermentation businesses use microorganisms to produce specific proteins such as dairy proteins. Other holdings focus on agricultural genetics, sustainable materials and clean energy linked to food systems. This diversity spreads risk across different approaches and markets.

For LSE:ANIC, the discount to NAV is the central valuation question. If portfolio companies continue to raise capital and reach commercial milestones, investors may become more willing to pay closer to stated asset value.

What Investors Are Watching Next

The key near-term catalyst for LSE:ANIC is the NAV calculation as at 30 September 2026, expected in the coming weeks. Investors will also look for fresh funding rounds, regulatory approvals and commercial launches across the portfolio, as well as any measures by the board to narrow the discount.